A phase I clinical trial of human embryonic stem cell‐derived retinal pigment epithelial cells for early‐stage Stargardt macular degeneration: 5‐years' follow‐up

OBJECTIVES: To evaluate the long‐term biosafety and efficacy of transplantation of human embryonic stem cells‐derived retinal pigment epithelial (hESC‐RPE) cells in early‐stage of Stargardt macular degeneration (STGD1). MATERIALS AND METHODS: Seven patients participated in this prospective clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shi‐Ying, Liu, Yong, Wang, Lei, Wang, Fang, Zhao, Tong‐Tao, Li, Qi‐You, Xu, Hai‐Wei, Meng, Xiao‐Hong, Hao, Jie, Zhou, Qi, Wang, Liu, Yin, Zheng‐Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450131/
https://www.ncbi.nlm.nih.gov/pubmed/34347352
http://dx.doi.org/10.1111/cpr.13100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450131/
https://www.ncbi.nlm.nih.gov/pubmed/34347352
http://dx.doi.org/10.1111/cpr.13100

Ejemplares similares